Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Neurology

PiB as antecedent biomarker of Alzheimer's disease

Victor Villemagne, Kerryn Pike, Rachel Mulligan, Uwe Ackermann, Gareth Jones, Henri Tochon-Danguy, Graeme O'Keefe, David Ames, Colin Masters and Christopher Rowe
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 248;
Victor Villemagne
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerryn Pike
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Mulligan
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Ackermann
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gareth Jones
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Tochon-Danguy
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme O'Keefe
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ames
3National Ageing Research Institute, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin Masters
2The Mental Health Research Institute, University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Rowe
1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 248

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Victor Villemagne1,
  2. Kerryn Pike1,
  3. Rachel Mulligan1,
  4. Uwe Ackermann1,
  5. Gareth Jones1,
  6. Henri Tochon-Danguy1,
  7. Graeme O'Keefe1,
  8. David Ames3,
  9. Colin Masters2 and
  10. Christopher Rowe1
  1. 1Dept of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  2. 2The Mental Health Research Institute, University of Melbourne, Melbourne, Australia
  3. 3National Ageing Research Institute, Melbourne, Australia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014200
Jan 2015200
Apr 2015200
May 2015200
Jun 2015100
Jul 2015200
Aug 2015100
Sep 2015600
Feb 2016100
Jul 2016100
Aug 2016200
Sep 2016100
Oct 2016300
Nov 2016100
Dec 2016200
Jan 2017100
Feb 2017200
Apr 2017100
Jun 2017100
Jul 2017100
Aug 2017300
Sep 2017200
Oct 2017500
Nov 2017100
Dec 2017100
Apr 2018200
Sep 2018200
Feb 2019100
Apr 2019100
Nov 2019100
Feb 2020500
Mar 20201400
Apr 2020900
Jul 2020100
Aug 20201700
Sep 20202600
Oct 2020500
Nov 2020800
Dec 2020700
Jan 2021500
Feb 20211500
Mar 20211500
Apr 20211500
May 2021600
Jun 2021800
Jul 20211700
Aug 20211200
Sep 2021500
Oct 2021600
Nov 20212200
Dec 20211200
Jan 20222700
Feb 2022800
Mar 2022700
Apr 2022500
May 20221200
Jun 2022300
Jul 2022100
Aug 2022300
Sep 2022100
Oct 2022200
Dec 2022100
Jan 2023100
Mar 2023200
Apr 2023200
May 2023400
Jun 2023300
Jul 2023100
Aug 2023300
Sep 2023100
Oct 2023100
Nov 2023100
Dec 2023300
Jan 2024500
Feb 2024100
Mar 2024200
Apr 2024300
May 2024200
Jun 2024500
Jul 2024300
Aug 2024700
Sep 2024500
Oct 2024100
Nov 2024200
Dec 2024600
Jan 2025200
Feb 2025200
Mar 2025300
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PiB as antecedent biomarker of Alzheimer's disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PiB as antecedent biomarker of Alzheimer's disease
Victor Villemagne, Kerryn Pike, Rachel Mulligan, Uwe Ackermann, Gareth Jones, Henri Tochon-Danguy, Graeme O'Keefe, David Ames, Colin Masters, Christopher Rowe
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 248;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PiB as antecedent biomarker of Alzheimer's disease
Victor Villemagne, Kerryn Pike, Rachel Mulligan, Uwe Ackermann, Gareth Jones, Henri Tochon-Danguy, Graeme O'Keefe, David Ames, Colin Masters, Christopher Rowe
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 248;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Neurology

  • Hemodynamic significance of abnormal magnetic resonance angiography findings assessed by acetazolamide-challenged brain perfusion SPECT
  • DaTSCAN low dose in scatter and attenuation corrected SPECT/CT imaging: Same diagnostic impact, less radiation exposure and improved cost-effectiveness
  • Changes in regional brain metabolism following initial therapy for breast cancer
Show more Neurosciences: Neurology

Dementia I: Healthy Aging/Diagnosis of Dementia

  • PET neurochemical vs. clinical phenotypes in mild-early dementia
  • The association of 11C-PIB uptake and cerebral glucose metabolism on 18F-FDG PET in Alzheimer's disease
Show more Dementia I: Healthy Aging/Diagnosis of Dementia

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire